PACTR201411000939962Completed未知
Open-label, non-randomised single arm trial to investigate the efficacy of Brincidofovir compared to historic controls for Ebolavirus Disease in an outbreak setting in West Africa.
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- niversity of Oxford
- Enrollment
- 140
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 Month(s) to 99 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Male and female patients 2 months of age or older
- •Laboratory confirmed infection with Ebolavirus infection.
- •Women who are lactating must agree to stop breastfeeding (a standard recommendation for all EVD patients)
- •Willingness to use barrier birth control for 3 months after recovery of EVD (a standard recommendation for all EVD patients)
- •For patients 18 years and older: the ability to provide fully informed consent or the provision of consent from the representative of a patient deemed too unwell to comprehend what is being asked of them.
- •For patients under 18 years: consent from a parent or guardian.
Exclusion Criteria
- •Any underlying disease or condition that, in the opinion of the principal investigator or treating physician, could jeopardize the participant¿s or healthcare workers safety or the participant¿s ability to comply with the protocol requirements
- •Patient unable to take oral IMP (e.g. severe vomiting unresponsive to anti-emetics, unconscious)
Investigators
Similar Trials
Recruiting
Phase 1
Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 years with pulmonary arterial hypertension (PAH)Pulmonary Arterial Hypertension (PAH)MedDRA version: 21.1Level: PTClassification code: 10064911Term: Pulmonary arterial hypertension Class: 100000004855CTIS2023-505082-91-00Aop Orphan Pharmaceuticals GmbH11
Completed
Phase 3
Single arm trial with afatinib to assess its safety in patients with non-small cell lung cancer(NSCLC)harboring EGFR mutation(s)CTRI/2014/08/004907Boehringer Ingelheim Hongkong50
Not yet recruiting
Phase 2
A Clinical Study to assess the effectiveness of Hariras Ayurvedic pills for symptomatic relief of Cough and Throat IrritatioCTRI/2024/03/064200Sushrutkrupa Ayurvedic Pharmacy Pvt. Ltd.
Active, not recruiting
Phase 3
A Japanese phase III multicenter, single-arm, open-label clinical trial to assess the efficacy and safety of the diagnosis/treatment of lymphedema by ICG fluorescent lymphangiography in patients with secondary lymphedemaJPRN-jRCT2031190064Akita Shinsuke50
Not yet recruiting
Phase 2
Clinical trial to study the combined effect of Ayurvedic formulations in Bronchial Asthma.CTRI/2024/05/067896ational Institute of Ayurveda Deemed to be University